Hemophilia gene therapy represents a groundbreaking advancement in the treatment of this inherited bleeding disorder, particularly hemophilia B.This innovative approach seeks to address the root cause of the condition by delivering a functional copy of the clotting factor IX gene directly into the patient's liver.